T. Rowe Price Associates’s MiMedx Group MDXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $486K | Buy |
79,303
+28,119
| +55% | +$172K | ﹤0.01% | 2314 |
|
|
2025
Q1 | $389K | Buy |
51,184
+4,738
| +10% | +$36K | ﹤0.01% | 2353 |
|
|
2024
Q4 | $447K | Buy |
46,446
+7,189
| +18% | +$69.2K | ﹤0.01% | 2323 |
|
|
2024
Q3 | $233K | Buy |
39,257
+1,510
| +4% | +$8.96K | ﹤0.01% | 2592 |
|
|
2024
Q2 | $262K | Buy |
37,747
+4,769
| +14% | +$33.1K | ﹤0.01% | 2486 |
|
|
2024
Q1 | $254K | Buy |
32,978
+3,806
| +13% | +$29.3K | ﹤0.01% | 2509 |
|
|
2023
Q4 | $256K | Sell |
29,172
-23,857
| -45% | -$209K | ﹤0.01% | 2440 |
|
|
2023
Q3 | $387K | Sell |
53,029
-1,424
| -3% | -$10.4K | ﹤0.01% | 2228 |
|
|
2023
Q2 | $360K | Buy |
54,453
+1,457
| +3% | +$9.63K | ﹤0.01% | 2278 |
|
|
2023
Q1 | $181K | Buy |
52,996
+8,233
| +18% | +$28.1K | ﹤0.01% | 2554 |
|
|
2022
Q4 | $124K | Buy |
44,763
+12,722
| +40% | +$35.2K | ﹤0.01% | 2671 |
|
|
2022
Q3 | $92K | Buy |
32,041
+7,106
| +28% | +$20.4K | ﹤0.01% | 2742 |
|
|
2022
Q2 | $87K | Buy |
24,935
+700
| +3% | +$2.44K | ﹤0.01% | 2775 |
|
|
2022
Q1 | $114K | Buy |
24,235
+2,482
| +11% | +$11.7K | ﹤0.01% | 2819 |
|
|
2021
Q4 | $131K | Sell |
21,753
-30,898
| -59% | -$186K | ﹤0.01% | 2829 |
|
|
2021
Q3 | $319K | Sell |
52,651
-2,600
| -5% | -$15.8K | ﹤0.01% | 2550 |
|
|
2021
Q2 | $691K | Sell |
55,251
-9,449
| -15% | -$118K | ﹤0.01% | 2218 |
|
|
2021
Q1 | $666K | Buy |
64,700
+31,600
| +95% | +$325K | ﹤0.01% | 2228 |
|
|
2020
Q4 | $301K | Buy |
+33,100
| New | +$301K | ﹤0.01% | 2418 |
|
|
2018
Q4 | – | Sell |
-22,759
| Closed | -$141K | – | 2570 |
|
|
2018
Q3 | $141K | Buy |
22,759
+719
| +3% | +$4.45K | ﹤0.01% | 2492 |
|
|
2018
Q2 | $141K | Buy |
22,040
+313
| +1% | +$2K | ﹤0.01% | 2490 |
|
|
2018
Q1 | $151K | Buy |
21,727
+11,202
| +106% | +$77.9K | ﹤0.01% | 2439 |
|
|
2017
Q4 | $133K | Buy |
+10,525
| New | +$133K | ﹤0.01% | 2464 |
|